Related Experiment Videos

Mutual inhibitory activities of tumor-degenerating factor (TDF) and fibronectin

A Tanaka1, Y Kakui, H Uemura

  • 1Department of Microbiology, Kyoto Prefectural University of Medicine, Japan.

Insights

Tumor-degenerating factor (TDF) from fibroblasts causes tumor cell changes. This study found fibronectin inhibits TDF activity, suggesting multiple fibronectin domains are essential for this interaction.

Area of Science:

  • Cell biology
  • Biochemistry
  • Cancer research

Background:

  • Previous studies identified a tumor-degenerating factor (TDF) secreted by human embryonic fibroblasts.
  • TDF induces "spongy degeneration-like" changes in human tumor cells in vitro.

Purpose of the Study:

  • To investigate the interaction between TDF and fibronectin.
  • To determine which domains of fibronectin are involved in inhibiting TDF activity.

Main Methods:

  • Coculture of tumor cells with fibroblasts.
  • Assays to measure TDF activity and fibronectin-mediated cell attachment.
  • Enzymatic (trypsin, thermolysin) and chemical (NTCB) degradation of fibronectin to identify active domains.

Main Results:

  • Fibronectin was found to inhibit TDF activity.
  • TDF inhibited cell attachment mediated by fibronectin.
  • Evidence suggests direct binding between TDF and fibronectin molecules.
  • Multiple fibronectin domains were identified as necessary for the inhibition of TDF activity.

Conclusions:

  • Fibronectin and TDF exhibit mutual inhibitory effects, likely through direct molecular binding.
  • The interaction involves multiple domains of fibronectin, highlighting its complex role in regulating TDF function.

Related Concept Videos